“CTHRC1 Is Associated With BRAF(V600E) Mutation and Correlates With Prognosis, Immune Cell Infiltration, and Drug Resistance in Colon Cancer, Thyroid Cancer, and Melanoma”. 2024. Biomolecules and Biomedicine 25 (1): 42–61. https://doi.org/10.17305/bb.2024.10397.